$EXEG OPKO HEALTH, INC. Insider Trading Week 15/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OPKO HEALTH, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in OPKO HEALTH, INC. in week 15/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.61 | 3,200 | 24,352 | 161,022,243 | 161 M to 161 M (0.00 %) |
| Apr 14 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.61 | 600 | 4,563 | 161,019,043 | 161 M to 161 M (0.00 %) |
| Apr 14 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.60 | 7,667 | 58,269 | 161,018,443 | 161 M to 161 M (0.00 %) |
| Apr 14 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.60 | 1,400 | 10,633 | 161,010,776 | 161 M to 161 M (0.00 %) |
| Apr 14 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.59 | 3,033 | 23,020 | 161,009,376 | 161 M to 161 M (0.00 %) |
| Apr 14 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.58 | 2,000 | 15,160 | 161,006,343 | 161 M to 161 M (0.00 %) |
| Apr 14 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.57 | 2,300 | 17,411 | 161,004,343 | 161 M to 161 M (0.00 %) |
| Apr 14 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.57 | 1,300 | 9,835 | 161,002,043 | 161 M to 161 M (0.00 %) |
| Apr 14 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.56 | 3,400 | 25,704 | 161,000,743 | 161 M to 161 M (0.00 %) |
| Apr 14 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.56 | 100 | 756 | 160,997,343 | 161 M to 161 M (0.00 %) |
| Apr 14 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.55 | 1,000 | 7,550 | 160,997,243 | 161 M to 161 M (0.00 %) |
| Apr 14 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.54 | 1,000 | 7,540 | 160,996,243 | 161 M to 161 M (0.00 %) |
| Apr 14 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.53 | 3,000 | 22,590 | 160,995,243 | 161 M to 161 M (0.00 %) |
| Apr 14 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.53 | 300 | 2,258 | 160,992,243 | 161 M to 161 M (0.00 %) |
| Apr 14 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.52 | 500 | 3,760 | 160,991,943 | 161 M to 161 M (0.00 %) |
| Apr 13 2017 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Option Exercise | M | 2.36 | 265,000 | 625,400 | 0 | |
| Apr 13 2017 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Payment of Exercise | F | 7.66 | 158,336 | 1,212,854 | 5,681,915 | 5.8 M to 5.7 M (-2.71 %) |
| Apr 13 2017 | EXEG | Opko Health, Inc. | Rubin Steven D | Executive VP-Admini ... | Buy | M | 2.36 | 265,000 | 625,400 | 5,840,251 | 5.6 M to 5.8 M (+4.75 %) |
| Apr 12 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.53 | 3,700 | 27,861 | 160,991,443 | 161 M to 161 M (0.00 %) |
| Apr 12 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.53 | 400 | 3,010 | 160,987,743 | 161 M to 161 M (0.00 %) |
| Apr 12 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.50 | 1,000 | 7,500 | 160,987,343 | 161 M to 161 M (0.00 %) |
| Apr 12 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.50 | 1,000 | 7,495 | 160,986,343 | 161 M to 161 M (0.00 %) |
| Apr 12 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.49 | 2,900 | 21,721 | 160,985,343 | 161 M to 161 M (0.00 %) |
| Apr 12 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.49 | 1,500 | 11,228 | 160,982,443 | 161 M to 161 M (0.00 %) |
| Apr 12 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.48 | 6,900 | 51,612 | 160,980,943 | 161 M to 161 M (0.00 %) |
| Apr 12 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.47 | 600 | 4,482 | 160,974,043 | 161 M to 161 M (0.00 %) |
| Apr 11 2017 | EXEG | Opko Health, Inc. | Yu Alice Lin-Tsing | Director | Option Exercise | M | 4.72 | 20,000 | 94,400 | 0 | |
| Apr 11 2017 | EXEG | Opko Health, Inc. | Yu Alice Lin-Tsing | Director | Buy | M | 4.72 | 20,000 | 94,400 | 100,000 | 80 K to 100 K (+25.00 %) |
| Apr 11 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.68 | 800 | 6,144 | 160,973,443 | 161 M to 161 M (0.00 %) |
| Apr 11 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.68 | 200 | 1,535 | 160,972,643 | 161 M to 161 M (0.00 %) |
| Apr 11 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.66 | 1,000 | 7,660 | 160,972,443 | 161 M to 161 M (0.00 %) |
| Apr 11 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.64 | 2,500 | 19,100 | 160,971,443 | 161 M to 161 M (0.00 %) |
| Apr 11 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.63 | 4,000 | 30,520 | 160,968,943 | 161 M to 161 M (0.00 %) |
| Apr 11 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.62 | 2,000 | 15,240 | 160,964,943 | 161 M to 161 M (0.00 %) |
| Apr 11 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.61 | 3,500 | 26,635 | 160,962,943 | 161 M to 161 M (0.00 %) |
| Apr 11 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.60 | 1,500 | 11,400 | 160,959,443 | 161 M to 161 M (0.00 %) |
| Apr 11 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.59 | 3,205 | 24,326 | 160,957,943 | 161 M to 161 M (0.00 %) |
| Apr 11 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.59 | 1,295 | 9,823 | 160,954,738 | 161 M to 161 M (0.00 %) |
| Apr 11 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.58 | 2,000 | 15,160 | 160,953,443 | 161 M to 161 M (0.00 %) |
| Apr 11 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.58 | 5,800 | 43,935 | 160,951,443 | 160.9 M to 161 M (0.00 %) |
| Apr 11 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.57 | 5,200 | 39,364 | 160,945,643 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.70 | 1,000 | 7,700 | 160,940,443 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.68 | 1,000 | 7,680 | 160,939,443 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.65 | 500 | 3,825 | 160,938,443 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.62 | 1,000 | 7,620 | 160,937,943 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.60 | 2,400 | 18,240 | 160,936,943 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.60 | 5,000 | 37,975 | 160,934,543 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.59 | 800 | 6,072 | 160,929,543 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.59 | 200 | 1,517 | 160,928,743 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.58 | 1,400 | 10,612 | 160,928,543 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.58 | 600 | 4,545 | 160,927,143 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.57 | 500 | 3,785 | 160,926,543 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.57 | 1,500 | 11,348 | 160,926,043 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.56 | 3,000 | 22,680 | 160,924,543 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.55 | 3,000 | 22,650 | 160,921,543 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.55 | 500 | 3,773 | 160,918,543 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.54 | 3,500 | 26,390 | 160,918,043 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.54 | 500 | 3,768 | 160,914,543 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.53 | 1,000 | 7,530 | 160,914,043 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.52 | 500 | 3,760 | 160,913,043 | 160.9 M to 160.9 M (0.00 %) |
| Apr 10 2017 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 7.52 | 100 | 752 | 160,912,543 | 160.9 M to 160.9 M (0.00 %) |